vs

Side-by-side financial comparison of CME Group (CME) and Wabtec (WAB). Click either name above to swap in a different company.

Wabtec is the larger business by last-quarter revenue ($3.0B vs $1.9B, roughly 1.6× CME Group). Wabtec runs the higher net margin — 12.3% vs 0.1%, a 12.2% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 13.0%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs 5.6%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Westinghouse Air Brake Technologies Corporation, commonly known as Wabtec, is an American company formed by the merger of the Westinghouse Air Brake Company (WABCO) and MotivePower in 1999. It is headquartered in Pittsburgh, Pennsylvania.

CME vs WAB — Head-to-Head

Bigger by revenue
WAB
WAB
1.6× larger
WAB
$3.0B
$1.9B
CME
Growing faster (revenue YoY)
CME
CME
+1.5% gap
CME
14.5%
13.0%
WAB
Higher net margin
WAB
WAB
12.2% more per $
WAB
12.3%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
5.6%
WAB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
WAB
WAB
Revenue
$1.9B
$3.0B
Net Profit
$1.2M
$363.0M
Gross Margin
36.0%
Operating Margin
0.1%
17.5%
Net Margin
0.1%
12.3%
Revenue YoY
14.5%
13.0%
Net Profit YoY
20.7%
11.0%
EPS (diluted)
$2.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
WAB
WAB
Q1 26
$1.9B
$3.0B
Q4 25
$1.6B
$3.0B
Q3 25
$1.5B
$2.9B
Q2 25
$1.7B
$2.7B
Q1 25
$1.6B
$2.6B
Q4 24
$1.5B
$2.6B
Q3 24
$1.6B
$2.7B
Q2 24
$1.5B
$2.6B
Net Profit
CME
CME
WAB
WAB
Q1 26
$1.2M
$363.0M
Q4 25
$1.2B
$202.0M
Q3 25
$908.0M
$310.0M
Q2 25
$1.0B
$336.0M
Q1 25
$956.2M
$322.0M
Q4 24
$874.6M
$212.0M
Q3 24
$912.8M
$283.0M
Q2 24
$883.2M
$289.0M
Gross Margin
CME
CME
WAB
WAB
Q1 26
36.0%
Q4 25
32.6%
Q3 25
34.7%
Q2 25
34.7%
Q1 25
34.5%
Q4 24
30.9%
Q3 24
33.0%
Q2 24
33.1%
Operating Margin
CME
CME
WAB
WAB
Q1 26
0.1%
17.5%
Q4 25
61.8%
12.0%
Q3 25
63.3%
17.0%
Q2 25
66.7%
17.4%
Q1 25
67.5%
18.2%
Q4 24
62.1%
12.9%
Q3 24
64.6%
16.3%
Q2 24
65.3%
16.3%
Net Margin
CME
CME
WAB
WAB
Q1 26
0.1%
12.3%
Q4 25
71.7%
6.8%
Q3 25
59.1%
10.7%
Q2 25
60.6%
12.4%
Q1 25
58.2%
12.3%
Q4 24
57.3%
8.2%
Q3 24
57.6%
10.6%
Q2 24
57.6%
10.9%
EPS (diluted)
CME
CME
WAB
WAB
Q1 26
$2.12
Q4 25
$3.24
$1.18
Q3 25
$2.49
$1.81
Q2 25
$2.81
$1.96
Q1 25
$2.62
$1.88
Q4 24
$2.40
$1.24
Q3 24
$2.50
$1.63
Q2 24
$2.42
$1.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
WAB
WAB
Cash + ST InvestmentsLiquidity on hand
$2.4B
Total DebtLower is stronger
$3.4B
$4.7B
Stockholders' EquityBook value
$11.1B
Total Assets
$202.0B
$23.2B
Debt / EquityLower = less leverage
0.42×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
WAB
WAB
Q1 26
$2.4B
Q4 25
$4.5B
Q3 25
$2.6B
Q2 25
$2.1B
Q1 25
$1.5B
Q4 24
$3.0B
Q3 24
$2.4B
Q2 24
$1.9B
Total Debt
CME
CME
WAB
WAB
Q1 26
$3.4B
$4.7B
Q4 25
$5.5B
Q3 25
$5.3B
Q2 25
$4.8B
Q1 25
$4.0B
Q4 24
$4.0B
Q3 24
$4.0B
Q2 24
$4.0B
Stockholders' Equity
CME
CME
WAB
WAB
Q1 26
$11.1B
Q4 25
$28.7B
$11.1B
Q3 25
$28.2B
$11.0B
Q2 25
$27.7B
$10.8B
Q1 25
$27.0B
$10.4B
Q4 24
$26.5B
$10.1B
Q3 24
$28.2B
$10.3B
Q2 24
$27.6B
$10.5B
Total Assets
CME
CME
WAB
WAB
Q1 26
$202.0B
$23.2B
Q4 25
$198.4B
$22.1B
Q3 25
$187.1B
$21.5B
Q2 25
$179.9B
$20.4B
Q1 25
$157.8B
$19.1B
Q4 24
$137.4B
$18.7B
Q3 24
$137.8B
$18.6B
Q2 24
$123.4B
$18.9B
Debt / Equity
CME
CME
WAB
WAB
Q1 26
0.42×
Q4 25
0.50×
Q3 25
0.48×
Q2 25
0.44×
Q1 25
0.39×
Q4 24
0.39×
Q3 24
0.39×
Q2 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
WAB
WAB
Operating Cash FlowLast quarter
$199.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.55×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
WAB
WAB
Q1 26
$199.0M
Q4 25
$1.1B
$992.0M
Q3 25
$968.1M
$367.0M
Q2 25
$1.1B
$209.0M
Q1 25
$1.1B
$191.0M
Q4 24
$1.0B
$723.0M
Q3 24
$1.0B
$542.0M
Q2 24
$776.9M
$235.0M
Free Cash Flow
CME
CME
WAB
WAB
Q1 26
Q4 25
$1.1B
$870.0M
Q3 25
$949.7M
$312.0M
Q2 25
$1.0B
$170.0M
Q1 25
$1.1B
$147.0M
Q4 24
$991.7M
$639.0M
Q3 24
$973.2M
$496.0M
Q2 24
$758.7M
$189.0M
FCF Margin
CME
CME
WAB
WAB
Q1 26
Q4 25
66.8%
29.3%
Q3 25
61.8%
10.8%
Q2 25
61.5%
6.3%
Q1 25
67.1%
5.6%
Q4 24
65.0%
24.7%
Q3 24
61.4%
18.6%
Q2 24
49.5%
7.1%
Capex Intensity
CME
CME
WAB
WAB
Q1 26
Q4 25
2.0%
4.1%
Q3 25
1.2%
1.9%
Q2 25
1.1%
1.4%
Q1 25
0.9%
1.7%
Q4 24
1.7%
3.3%
Q3 24
1.9%
1.7%
Q2 24
1.2%
1.7%
Cash Conversion
CME
CME
WAB
WAB
Q1 26
0.55×
Q4 25
0.96×
4.91×
Q3 25
1.07×
1.18×
Q2 25
1.03×
0.62×
Q1 25
1.17×
0.59×
Q4 24
1.16×
3.41×
Q3 24
1.10×
1.92×
Q2 24
0.88×
0.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons